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ARTICLE
Pleiotropic Meta-Analysis of Cognition, Education, and
Schizophrenia Differentiates Roles of Early
Neurodevelopmental and Adult Synaptic Pathways
Max Lam,1,2,3 W. David Hill,4,5 Joey W. Trampush,6 Jin Yu,2 Emma Knowles,7 Gail Davies,4,5
Eli Stahl,8,9,10 Laura Huckins,8,9,10 David C. Liewald,5 Srdjan Djurovic,11,12 Ingrid Melle,12,13
Kjetil Sundet,13,14 Andrea Christoforou,15 Ivar Reinvang,14 Pamela DeRosse,2 Astri J. Lundervold,16
Vidar M. Steen,12,15 Thomas Espeseth,13,14 Katri Ra¨ikko¨nen,17 Elisabeth Widen,18 Aarno Palotie,18,19,20
Johan G. Eriksson,21,22,23 Ina Giegling,24 Bettina Konte,24 Annette M. Hartmann,24
Panos Roussos,8,9,10,25 Stella Giakoumaki,26 Katherine E. Burdick,8,25,27 Antony Payton,28
William Ollier,29,30 Ornit Chiba-Falek,31,32 Deborah K. Attix,31,32,33,34 Anna C. Need,35
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Susceptibility to schizophrenia is inversely correlated with general cognitive ability at both the phenotypic and the genetic level. Para-
doxically, a modest but consistent positive genetic correlation has been reported between schizophrenia and educational attainment,
despite the strong positive genetic correlation between cognitive ability and educational attainment. Here we leverage published
genome-wide association studies (GWASs) in cognitive ability, education, and schizophrenia to parse biological mechanisms underlying
these results. Association analysis based on subsets (ASSET), a pleiotropic meta-analytic technique, allowed jointly associated loci to be
identified and characterized. Specifically, we identified subsets of variants associated in the expected (‘‘concordant’’) direction across all
three phenotypes (i.e., greater risk for schizophrenia, lower cognitive ability, and lower educational attainment); these were contrasted
with variants that demonstrated the counterintuitive (‘‘discordant’’) relationship between education and schizophrenia (i.e., greater risk
for schizophrenia and higher educational attainment). ASSET analysis revealed 235 independent loci associated with cognitive ability,
education, and/or schizophrenia at p< 53 108. Pleiotropic analysis successfully identifiedmore than 100 loci that were not significant
in the input GWASs. Many of these have been validated by larger, more recent single-phenotype GWASs. Leveraging the joint genetic
correlations of cognitive ability, education, and schizophrenia, we were able to dissociate two distinct biological mechanisms—early
neurodevelopmental pathways that characterize concordant allelic variation and adulthood synaptic pruning pathways—that were
linked to the paradoxical positive genetic association between education and schizophrenia. Furthermore, genetic correlation analyses
revealed that these mechanisms contribute not only to the etiopathogenesis of schizophrenia but also to the broader biological dimen-
sions implicated in both general health outcomes and psychiatric illness.
Introduction
It has long been observed that impaired cognitive ability is
a significant aspect of the illness in schizophrenia (MIM:
181500).1–5 Cognitive deficits have been shown to be
largely independent of clinical state and treatment status
in patients with schizophrenia1,4,6–9 and are observed (in
more subtle forms) in their first-degree relatives.10,11
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Moreover, cognitive deficits precede illness onset by many
years; they begin in early childhood5,12–14 and thus result
in reduced educational attainment.15,16
Unlike phenotypic correlation, which measures covari-
ances within the distribution of the phenotypes, genetic
correlation (rg) indexes the covariance between SNPzphe-
notype genome-wide association study (GWAS) effect sizes
across a pair of phenotypes measured in separate GWAS
studies. Recent advances in psychiatric and cognitive
genomics have reliably demonstrated that the inverse
relationship between cognitive ability and risk for schizo-
phrenia is also observed at the molecular genetic level
(rgz .20).17–23 Paradoxically, genetic correlation studies
have indicated a positive relationship between educational
attainment and risk for schizophrenia (rg z .10),
20,23–27
despite the fact that educational attainment and cogni-
tive ability exhibit a very strong polygenic overlap
(rg z .70).
18,23,27 Educational attainment is often consid-
ered to be a proxy for cognitive ability; however, the lack
of perfect genetic overlap between the two, combined
with the paradoxical genetic correlation between educa-
tional attainment and schizophrenia, suggests an opportu-
nity to decompose distinct genetic mechanisms account-
ing for this pattern of results.
Whereas genetic-correlation analysis has recently
become widespread because of the availability of tech-
niques such as linkage disequilibrium (LD) score regression
(LDSC),25,28 these approaches generally result in a single,
genome-wide estimate of polygenic overlap. Moreover,
novel meta-analytic approaches (e.g., multi-trait analysis
of GWAS [MTAG]29) for merging seemingly heterogeneous
GWAS datasets tend to exploit commonalities across phe-
notypes rather than differences; for example, two recent
studies have employed MTAG across the highly correlated
cognitive and educational GWASs in order to accelerate the
process of gene discovery.18,23 In contrast, few studies have
attempted to examine the counter-intuitive correlation be-
tween schizophrenia and educational attainment or to
parse subsets of SNPs that might drive cross-phenotype
correlations. An initial effort has successfully identified a
few individual loci that act in paradoxical fashion,
increasing educational attainment while simultaneously
increasing risk for schizophrenia;30 two other studies
have identified loci that demonstrate other pleiotropic
effects.19,31
To date, however, no studies have utilized pleiotropic
meta-analytic techniques to comprehensively parse vari-
ance from cognitive, educational, and schizophrenia-
focused GWASs that might pinpoint differential biological
mechanisms. In order for the paradoxical pattern of
genome-wide correlations to exist, there must be identifi-
able subsets of SNPs that are differentially involved in
driving these genetic relationships. Therefore, we sought
to identify differentially associated variants, which could
yield crucial insights into the fine-grained genetic architec-
ture of schizophrenia and in turn give us insights into the
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etiopathogenic mechanisms underlying the illness—
mechanisms that standard GWAS cannot detect.
In the study reported here, we first utilized a simple sub-
setting approach to identify SNPs that are significantly
associated either with cognitive ability or with educational
attainment, but not with both (Figure S1A). We hypothe-
sized that these SNP subsets would demonstrate stronger
genetic correlations with schizophrenia than what is
observed with a simple genome-wide approach. We then
employed a pleiotropic meta-analytic approach, associa-
tion analysis based on subsets (ASSET),32 which permits
the characterization of each SNP with respect to its pattern
of effects on multiple phenotypes (Figure S1B). For
example, ASSET has previously been used to demonstrate
that the minor allele of rs2736100 (at the TERT [MIM:
187270] locus) is positively associated with risk for pancre-
atic cancer (MIM: 260350), negatively associated with risk
for kidney (MIM: 144700) and lung cancers (MIM:
211980), and not significantly associated with risk for can-
cers of the breast (MIM: 114480), bladder (MIM: 109800),
or prostate (MIM: 176207); other cancer loci were demon-
strated to have various other patterns of effects.32 We uti-
lized ASSET to identify two types of loci: (1) those SNPs
that are consistently associated with all three phenotypes
in the expected direction (i.e., the same allele is associated
with higher cognitive ability, higher educational attain-
ment, and lower risk for schizophrenia), which we label
‘‘concordant,’’ and (2) SNPs that demonstrate the paradox-
ical association between education and schizophrenia (i.e.,
the same allele associated with higher educational attain-
ment and higher risk for schizophrenia), which we labeled
‘‘discordant.’’ Next, we compared the statistically signifi-
cant ASSET results to the output of single-trait GWASs
of cognitive ability, educational attainment, or schizo-
phrenia20,33,34 in order to identify novel loci suggested
by ASSET. Subsequently, we conducted a series of pathway
and transcriptome-wide analyses to biologically charac-
terize differential mechanisms underlying concordant
versus discordant loci. Finally, we performed a series of ge-
netic correlation analyses to compare the overlap of
concordant and discordant SNP subsets with other rele-
vant traits. Further analytic details are covered in the Mate-
rial and Methods section; the full analysis workflow is also
represented in Figures S1 and S2.
Material and Methods
Stage 1: Simple Subsetting Approach Based on p Values
in Cognition and Education GWAS
Note that for most purposes in this manuscript, we are using the
largest GWAS for schizophrenia,35 cognitive ability,18 and educa-
tional attainment36 published prior to 2018. For each of these
phenotypes, larger GWASs have been published in 2018; these
were used for validation and extension as described in subsequent
sections. Before we performed wany subsetting analyses, we used
genome-wide genetic correlations to confirm the earlier observed
genetic correlations between schizophrenia and both cognitive
ability and education. In stage 1, preliminary SNP subsets were
formed simply based on p value thresholds of cognitive ability
and educational attainment GWAS: (1) SNPs nominally associated
with cognition (p < 0.05) and not associated with education
(p > 0.05) were selected, resulting in 74,470 SNPs; (2) SNPs nomi-
nally associated with cognition (p < 0.05) and not associated with
education using a stricter threshold (p > 0.5) were selected, result-
ing in 66,657 SNPs; (3) similar procedures were carried out for
SNPs nominally associated with education (p < 0.05) but not
with cognition (p > 0.05), were selected, resulting in 104,807
SNPs; and (4) SNPs nominally associated with education
(p < 0.05) and not cognition using a stricter threshold (p > 0.5)
were selected, resulting in 44,803 SNPs.
Next, we performed a heterogeneity test between results of
cognitive and educational GWAS by usingMETAL37 and generated
sets of SNPs showing opposite effects between the two (i.e., the
same allele predicts better cognitive performance but less educa-
tional attainment, and vice versa). We identified sets of SNPs of
varying sizes on the basis of varying p value thresholds for the het-
erogeneity tests (p< 0.5; p< 0.25; p < 0.1; p < 0.05; p< 0.01; and
p < 0.001).
To evaluate the degree of genetic correlation of these prelimi-
nary subsets of SNPs with respect to schizophrenia, we utilized
GNOVA,38 a recently published method similar to LD score regres-
sion. GNOVA is specifically designed to examine genetic correla-
tions using SNP subsets (rather than global genome-wide
summary statistics), whereas such applications have not been
explicitly tested in LD score regression and may not be robust.
Stage 2: ASSET Meta-Analysis and ASSET-Generated
SNP Subsets
Schizophrenia GWAS summary statistics based on a European
ancestry GWAS of schizophrenia (n ¼ 77,096, cases ¼ 33,640,
controls ¼ 43,456; GWAS mean c2 ¼ 1.677) were obtained
from the Psychiatric Genomics Consortium.35 To make them
compatible with effect sizes (beta weights) derived from the
linear-regression-based cognition and education GWASs, we con-
verted odds ratios from the case-control schizophrenia GWAS to
beta by taking the natural logarithm of the odds ratios. Effect di-
rection per SNP was also reversed for schizophrenia so thatit
would be consistent with the interpretation of cognition and
education (i.e., concordant alleles are those where the direction
of effect is the same for cognitive ability, educational attainment,
and schizophrenia). Summary statistics for the education GWAS
were obtained from the Social Science Genomics Association
Consortium (SSGAC)36 (n ¼ 328,917, GWAS mean c2 ¼ 1.638).
GWAS summary statistics for cognition are available via earlier in-
verse-variance meta-analysis of samples18 from the COGENT27
consortium (n ¼ 107,207, GWAS mean c2 ¼ 1.245). We applied
general quality-control parameters to the schizophrenia and
cognitive GWAS summary statistics but we excluded SNPs
with INFO scores < 0.6 and minor-allele frequency < 0.01; mul-
tiple quality-control parameters’ thresholds were previously re-
ported for the education GWAS,36 and summary statistics were
provided by the SSGAC. Detailed quality-control and meta-ana-
lytic procedures were reported earlier.18 Only SNPs that were
present for all three phenotypes were retained as inputs to the
ASSET meta-analysis, resulting in 7,306,098 SNPs for subsequent
analysis.
Pooling GWAS summary statistics via conventional inverse-vari-
ance meta-analysis increases power but also poses methodological
336 The American Journal of Human Genetics 105, 334–350, August 1, 2019
challenges when different studies are capturing heterogeneous
and/or pleiotropic phenotypes. In the case of pleiotropy, individ-
ual variants are likely to be associated with only a subset of the
traits analyzed, or theymight even demonstrate effects in different
directions for the different phenotypes under analysis. ASSET
meta-analysis32 is an agnostic approach that generalizes standard
fixed-effects meta-analysis by allowing a subset of the input
GWASs to have no effect on a given SNP, and it exhaustively
searches across all possible subsets of ‘‘non-null’’ GWAS inputs
within a fixed-effect framework to identify the strongest associa-
tion signal in both positive and negative directions. ASSET then
evaluates the significance of these positive and negative associa-
tions while accounting for multiple testing. This methodology
allows for a powerful pooled two-tailed Z-score test statistic that
effectively combines p values for variants with strong effects in
opposite directions across input GWASs. ASSET also permits the
addition of a covariance term for the adjustment of overlapping
samples. The genetic correlation matrix between the three input
GWASs had been added to all reported ASSET analyses so that
this adjustment could be performed. Recently, comparisons be-
tween cross-phenotype meta-analysis methodologies demon-
strated that ASSET performed best as the number of meta-analyzed
traits with null effects increased, and ASSET also did well in terms
of specificity and sensitivity of the results. In addition, the ASSET
approach best controlled for potential Type 1 inflation due to sam-
ple overlap and for non-uniform distribution of effect sizes.39 As
such, for the purpose of the current report, we selected ASSET
for its conservative effect estimates and minimal inflation.
A
B
Figure 1. Design of the Present Study
(A) Input GWAS studies used for ASSET
analysis.
(B) Definition of concordant and discor-
dant SNP subsets. Concordant SNPs have
alleles that demonstrate negative effects
on cognitive ability, educational attain-
ment, and schizophrenia risk (i.e.,
increased schizophrenia risk, reverse-coded
for consistency). Discordant SNPs have al-
leles that demonstrate paradoxical effects
on educational attainment and schizo-
phrenia (i.e., higher educational attain-
ment and increased schizophrenia risk,
reverse-coded). The Y axes on the forest
plots represent different input summary
statistics for cognition, education, and
schizophrenia.
We combined GWAS summary statistics
from schizophrenia, cognition, and educa-
tion by using ASSET two-tailed meta-anal-
ysis (version 1.9.1) to obtain single cross-
phenotype pleiotropic GWAS results.
Default parameters were applied with the
‘‘h.traits’’ function. Inter-study correlations
of the phenotype were first ascertained
via LDSC,25,28 which accounts for the
genome-wide genetic correlation of the
phenotypes and also for sample overlap.
ForeachgivenSNP,ASSETgeneratesZ scores
of effect size and p values based on the
strongest association from the input studies
in positive and negative directions, respec-
tively; then these p values are pooled into a single two-tailed p value
for pleiotropy.32,39 SNPs with similar relationships across the input
traits (regardless of statistical significance) are then grouped into
subsets identified by ASSET (see Figure 1B and Figure S1, bottom).
Again, as noted above, it is important to emphasize that the per-
SNP direction of effect was reversed for schizophrenia so that it was
consistent with the interpretation of cognition and education (i.e.,
higher scores are better, such that higher scores for schizophrenia
are now coded as decreased risk for the disorder). Thus, in the nota-
tions to follow,X represents variant subsetswith the same effect di-
rections, following the reversal of the direction of effect for the
schizophrenia dataset, and j represents traits whose effect sizes
are in the opposite direction of those for the other two traits (again
following the reversal of the direction of effect for the schizo-
phrenia dataset). ASSET subsets included: (1) scz X edu X cog
(concordant, variants with an allele associated with an increase in
cognitive ability and educational attainment, but a decrease in
schizophrenia risk); (2) eduX cog j scz (schizophrenia outliers, var-
iants associated with an increase in cognitive ability and educa-
tional attainment but also with an increase in schizophrenia
risk); (3) scz X cog j edu (education outliers, variants associated
with an increase in schizophrenia risk and reduced cognitive abil-
ity, but an increase in educational attainment); and (4) scz X
edu j cog (cognition outliers, variants associated with an increase
in schizophrenia risk and reduced educational attainment, but an
increase in cognitive ability) subsets. ASSET also identified SNPs
where only a single trait (scz or edu or cog) was significant; these
were included in a category called ‘‘single phenotype.’’
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Finally, to generate an appropriate contrast for the ‘‘concordant’’
subset, we included a combined single ‘‘discordant’’ subset, repre-
senting the counter-intuitive genetic correlation between educa-
tion and schizophrenia, where discordant ¼ (edu X cog j scz) þ
(scz X cog j edu) [subsets 2 and 3 above], regardless of the effect
for cognition. These contrasts are also represented visually in
Figure 1 and Figure S1.
Consolidation of Independent Loci
Independent genome-wide-significant loci for each ASSET meta-
analysis subset were identified via SNP clumping procedures that
are a part of the functional mapping and annotation (FUMA) pipe-
line.40 For the LD-rich MHC region, a single top SNP was retained.
For all other loci, clumping procedures were carried out on the ba-
sis of the European 1000 Genomes Project phase 3 reference panel.
First, ‘‘independent significant SNPs’’ were defined as those SNPs
with a p value < 5 3 108 and with an LD of r2 < 0.6 and other,
more significant SNPs at the same locus. Second, candidate SNPs
were then identified for subsequent annotations and were defined
as all SNPs that had an MAF of 0.01 and a maximum p value of
0.05 and that were in LD, with r2 R 0.6, with at least one of the
independent significant SNPs. To ensure that biological annota-
tion of these loci would not be hampered by poor coverage at
any locus, we included SNPs that came from the 1000 Genomes
reference panel but that might not have been included in the
ASSET data. Third, ‘‘lead SNPs’’ were defined as the independent
significant SNPs that had the strongest signal at a given locus
and were strictly independent from each other (r2 < 0.1). Finally,
risk loci that were 250 kb or closer were merged into a single
locus. The FUMA procedure was iterated across all ASSET SNP sub-
sets, which were comprised (by definition) of non-overlapping
SNPs. Additional variant annotations were conducted with
ANNOVAR,41 and lookups with published GWASs were conducted
with the GWAS catalog. Additional SNP lookups were performed
with the input summary statistics (cognition, education, and
schizophrenia GWASs18,35,36), recent MTAG analyses of intelli-
gence,23 recent cognition or intelligence20,21 GWASs, and pleio-
tropic analyses of cognition and schizophrenia19 as well as
education and schizophrenia.31 RAggr43 was utilized for extracting
SNPs within 250 kb and r2 > 0.6 from published reports to allow
merging of loci generated from ASSET subsets.
MAGMA Gene-Based Analysis: Tissue Expression and
Competitive Pathway Analysis
SNPs were mapped to 19,436 protein-coding genes via MAGMA as
implemented in the FUMA40 pipeline. MAGMA44 gene analysis
was performed with a default SNP-wide mean model that used
the 1000 Genomes phase 3 reference panel and default gene anno-
tations that are part of the FUMA pipeline. Genome-wide SNP
p values and SNP-level sample sizes were included in the input
files. MAGMA gene-tissue expression analysis was carried out
with the Genotype-Tissue Expression (GTEx; version 745–47)
resource to examine the relationship between gene expression in
a specific tissue type and ASSET results. The gene-property test
was performed for average expression (log2-transformed RPKM
with pseudocount 1 after winsorization at 50) of 53 specific tissue
types conditioning on average expression across all tissue types.
In order to identify specific biological processes linked to our sub-
phenotypes of interest, we also used the results that emerged from
the ASSETanalysis to conductMAGMA competitive pathway anal-
ysis. Gene sets that were tested included drug-related path-
ways,48,49 as well as custom-curated neurodevelopmental and
other brain-related gene sets that had gone through stringent qual-
ity control in a studyoriginally designed to interrogate rare variants
in schizophrenia.50 In the latter, pathways with more than 100
genes from Gene Ontology (release 146; June 22, 2015 release),
KEGG (July 1, 2011 release), PANTHER (May 18, 2015 release),
REACTOME (March 23, 2015 release), DECIPHER Developmental
Disorder Genotype-Phenotype (DDG2P) database (April 13, 2015
release), and theMolecular SignaturesDatabase (MSigDB)hallmark
processes (version 4, March 26, 2015 release) were initially
included. Brain-level tissue expressiongene sets included theBrain-
span RNA-seq dataset51 and the GTEx v7 dataset.45 MAGMA gene-
based and gene-set analysis were conducted with MAGMA v1.6.44
Additional gene sets were selected on the basis of risk for schizo-
phrenia and neurodevelopmental disorders, including those re-
ported for schizophrenia rare variants52 (translational targets of
FMRP [MIM: 309550]; components of the post-synaptic density;
ion channel proteins; components of the ARC, mGluR5, and
NMDARcomplexes;proteinsat cortical inhibitory synapses; targets
of mir-137; and genes near schizophrenia common risk loci) and
autism (MIM: 613436) risk (targets of CHD8 [MIM: 610528], splice
targets of RBFOX [MIM: 605104], hippocampal gene expression
networks, and neuronal gene lists from theGenes2Cognition data-
base, as well as loss-of-function [LoF]-intolerant genes [pLI > 0.9
from the ExAC v0.3.1 pLI metric], ASD risk genes for FDR < 10%
and 30%, and ASD or developmental disorder de novo genes hit
by an LoF and/or missense de novo variant). Further details of cura-
tion of these gene sets was previously reported.50
S-PrediXcan: Brain-Tissue Expression Profiles and
Hypergeometric Gene-Set Enrichment Analysis
Genetically regulated gene expression was imputed for the ASSET
summary statistics with tissuemodels fromGTEx v7 and the Com-
monMind Consortium via S-PrediXcan (formerly MetaXcan).53–55
GTEx v7 tissue included amygdala (n¼ 88), anterior cingulate cor-
tex (n ¼ 109), basal ganglia (n ¼ 144), cerebellar hemisphere
(n ¼ 125), cerebellum, cortex (n ¼ 136), frontal cortex (n ¼
118), hippocampus (n ¼ 111), hypothalamus (n ¼ 108), nucleus
accumbens (n ¼ 130), putamen (n ¼ 111), spinal cervical-1 (n ¼
83), and substantia nigra (n¼ 80). The CommonMind consortium
data consist of tissue expression data derived from the dorsolateral
prefrontal cortex (DLPFC, n ¼ 279).56 GTEX v7 Tissue expression
models were trained using elastic net models that were made pub-
licly available (see Web Resources). Elastic net models for DLPFC
were contributed by collaborators from the CommonMind Con-
sortium.56–58 Bonferroni correction was first conducted for each
ASSET subset of genes. Genes that survivedmultiple testing correc-
tions were entered into GENE2FUNC, which is part of the FUMA40
pipeline, to be tested for over-representation. This analysis differs
from the MAGMA gene-set analysis in that the MAGMA gene-set
analysis is used to examine whether gene sets, united by a known
biological theme, are enriched for the phenotype under investiga-
tion. In a test of over-representation, as conducted with
GENE2FUNC, the shared function of the genes of interest is un-
known, and its elucidation is the goal of a test of over-representa-
tion. The over-representation test conducted with GENE2FUNC
queries gene sets from (1) the Molecular Signature Database
(MsigDB v 5.2), (2) WikiPathways (curated version 20161010),
and (3) GWAS catalog (reported genes ver e91 20180206); to avoid
spurious results, we required a minimum of three genes per
pathway. For each gene set, hypergeometric tests were conducted
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so that the list of genes significant in each ASSET subset could be
examined for overlap with gene sets within the databases stipu-
lated above; Bonferroni correction for multiple testing was
applied. To reduce the likelihood that hypergeometric pathway
analysis would be influenced by the dense number of genes within
the MHC region, we removed genes within the coordinates of
28,000,000–35,000,00059 on chromosome 6.
Genetic Correlations
To examine how our ASSET concordant and discordant SNP sub-
sets relate to other phenotypes with available GWAS data, we con-
ducted genetic correlation tests by using GNOVA,38 an approach
similar to LD score regression but capable of working with SNP
subsets. Notably, GNOVA provides a corrected rg that has been
demonstrated to be robust to sample overlaps, and GNOVA is
able to account for LD across SNPs.38 We selected a series of neuro-
psychiatric, inflammatory, brain, metabolic, and cardiovascular
phenotypes that have been previously demonstrated to have ge-
netic correlations with cognitive measures and used them to inter-
rogate the genetic overlaps of our ASSET subsets. Interpretation of
GNOVA for the concordant subset was straightforward because the
three input GWASweights all follow the same direction (following
the reverse coding of schizophrenia, as noted previously). In
contrast, discordant SNPs have two separate potential weights
(allelic b for schizophrenia versus allelic b for education); as shown
in Figure 1B, a given SNP might have somewhat different effect
sizes (distances from the center line) for education as compared
to schizophrenia. Therefore, we weighted each SNP by the stron-
ger value of b: variants for which the schizophrenia b was stronger
than the education b were referred to as ‘‘schizophrenia type’’ and
variants with the opposite pattern were referred to as ‘‘education
A
B
Figure 2. Genetic Correlations with
Schizophrenia for SNPs Demonstrating
Heterogeneity of Effects between (A)




Genetic correlation was carried out with
GNOVA. Error bars represent standard er-
rors. Education ¼ Okbay PMID 27225129;
cognition ¼ Lam PMID 29186694; schizo-
phrenia (Ripke) ¼ PGC Schizophrenia
Working Group PMID 25056061.
type.’’ Nevertheless, it is important to
emphasize that the discordant SNPs repre-
sent a single dimension of biology, and the
net effects of all ‘‘schizophrenia type’’ vari-
ants were equivalent to those of the ‘‘educa-
tion type’’ SNPs, albeit with opposite signs.
Results
Stage 1: Preliminary Evaluation of
Genetic Correlations
We used GWAS summary statistics
for cognition (n ¼ 107,207)18 and
education (n ¼ 328,917)36 to evaluate
preliminary genetic correlations with
schizophrenia (n¼ 77, 096).35 Consistent with previous re-
sults, the inverse genetic correlation that GNOVA revealed
between cognition and schizophrenia was significant
(rg ¼ .21, se ¼ 0.03, p ¼ 1.12 3 1012), as was the
counter-intuitive positive correlation between education
and schizophrenia (rg ¼ 0.08, se ¼ 0.02, p ¼ 2.05 3
105). Note that these analyses were conducted before we
reversed the direction of effect for schizophrenia.
Prior to the main ASSET analysis, we used two simple ap-
proaches to examine subsets of SNPs and their association
with schizophrenia (Figure S1). First, we selected SNPs that
were nominally associated with education (p < 0.05) and
generally not associated with cognition (p> 0.05); GNOVA
revealed a slightly stronger positive correlation, rg of 0.17,
between this subset of educational attainment SNPs and
schizophrenia than did genome-wide summary statistics
(Figure 2A). With a stricter threshold for SNPs not associ-
ated with cognition (p > 0.50), these ‘‘non-cognitive’’
educational attainment SNPs also attained an rg of 0.17
with schizophrenia. GNOVA analyses were repeated for
SNPs nominally associated with cognition (p < 0.05),
but generally not associated with education (p > 0.05),
and the analyses were repeated again with the stricter
threshold for education (p > 0.50). Values for rg of .50
and .11 were obtained between schizophrenia and these
cognition subsets (Figure 2A).
The second approach involved calculating the heteroge-
neity p values for cognition and education and identifying
SNPs that have discrepant direction of effects between
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cognition and education. These SNPs were then binned,
ranging from low probability (p < 0.5) to high probability
(p < 0.001) for heterogeneous effect sizes between cogni-
tion and education (Figure 2B). GNOVA indicated that
the greater the discrepancy in effect direction between
SNP effects for cognition and education, the stronger the
association between cognition and schizophrenia. How-
ever, this pattern was not observed for education and
schizophrenia.
Stage 2: ASSET Meta-Analysis and SNP Subsets
Genome-wide cross-phenotype ASSETmeta-analysis across
7,306,098 SNPs revealed 300 lead SNPs (across 236 inde-
pendent loci) that met the genome-wide significance
threshold of p < 5 3 108 for the ASSET two-tailed test
(see Figure 3A and Tables S1 and S2). There were
1,381,020 SNPs that demonstrated consistent direction of
effects between cognition, education, and schizophrenia
(i.e., lower cognitive ability, lower educational attainment,
and increased risk for schizophrenia); these were assigned
to the ‘‘concordant’’ subset, which contained 89 genome-
wide-significant loci harboring 103 independent signifi-
cant SNPs. By contrast, the ‘‘discordant’’ subset, which
consisted of SNPs with counter-intuitive allelic effects for






schizophrenia vis-a`-vis education, en-
compassed 1,891,743 SNPs, with 65
genome-wide-significant loci com-
prising 77 independent significant
SNPs (Figures 3B and 3C and Table
S1). Significant loci for other ASSET
subsets are also detailed in Table S2.
Other supplemental tables show
FUMA-derived annotations for poten-
tial functional consequences, includ-
ing CADD scores (Table S3), eQTL
lookups (Table S4), and prior GWAS
lookups (Table S5).
Consolidation of Independent Loci
Next, we wanted to identify which
loci from our ASSET results were not
previously identified with respect
to the three-input GWAS. Using
RAggr,43 we extracted SNPs with r2 >
0.6 within a window of 250 kb of
lead SNPs in reported GWASs, i.e., we
extracted 101 loci from the Euro-
pean-ancestry cohorts of the Psychiat-
ric Genomics Consortium GWAS of
schizophrenia,35 74 loci from the SSGAC educational
attainment GWAS,36 and 40 loci from the COGENT
GWAS of cognitive ability.18 These were merged with the
236 loci from ASSET. As earlier described, independent
loci within 250 kb were merged, resulting in 280 indepen-
dent loci being identified across ASSET and the input
GWAS. As shown in the resulting Venn diagram (Figure 4),
110 loci not reported earlier were identified by the ASSET
meta-analysis. In contrast, 126 loci overlapped with either
education or schizophrenia, whereas 44 loci were only sig-
nificant in the input GWAS and not in ASSET.
Very recently, new GWASs have been published for
schizophrenia, cognitive ability, and educational attain-
ment, and these studies are larger than the input GWAS
used for our ASSET analysis.20,33,34 This permitted us to
perform a lookup of our 110 ‘‘novel’’ ASSET SNPs, thus
providing an opportunity to validate ASSET as a tool for lo-
cus discovery (Table S6). We also performed lookup in a pa-
per that utilized MTAG to examine intelligence20 and
several recent papers that applied pleiotropic approaches
to these phenotypes.19,23,31 We found that 75% of the
loci were in fact reported as significant in the later GWASs
with larger sample sizes, and 28 of the 110 loci were
independent from other single-phenotype GWAS reports.
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These loci are reported in Table 1. Notably, three of these
loci (indexed by rs207338, rs708212, and rs11617058)
were identified in secondary analyses (using MTAG) per-
formed in the study of educational attainment,34 and
one locus (rs67652508) has been reported as being
genome-wide significant for association to putamen vol-
umes as measured on magnetic resonance imaging (MRI)
scans of the brain.60 Further ANNOVAR41 annotations
are available for novel loci (Table S7).
MAGMA Gene-Based Analysis: Tissue-Expression and
Competitive-Pathway Analysis
MAGMA gene-based analysis was conducted on all ASSET
subsets. 772 genes survived Bonferroni correction in the
overall ASSET analysis, with 306 genes in the concordant
subset and 304 genes within the discordant subset (Table
S8). MAGMA gene property analysis revealed significant
association (p < 0.000926, Bonferroni-corrected) of gene
expression of ASSET SNP subsets across GTExv7 brain
tissues (Figure S3 and Table S9). There were no significant
differences between concordant and discordant result sub-
sets; both subsets were significantly enriched (positive beta
weights) across all brain compartments.
Because of the significant enrichment in brain tissues,
we next performed MAGMA competitive-pathway ana-
lyses by using neurodevelopmental and other brain-related
gene sets as curated in a recent publication;50 full results
are reported in Table S10. Although there was considerable
overlap of pathway enrichment across ASSET categories,
several gene sets were uniquely associated with either the
concordant or the discordant result subsets (Table 2). Spe-
cifically, the CHD8 pathway, reflecting genes involved in
early neurodevelopment, was uniquely associated with
the concordant subset (p ¼ 7.11 3 106). In contrast, a
number of synaptic pathways (e.g., ion-channel and syn-
aptic-density pathways) and constrained gene sets ap-
peared to be uniquely associated with the discordant
subset. Only two gene sets were enriched in both the
concordant and the discordant results, and these were
rather generic: brain-enriched genes and schizophrenia
GWAS results (Table S10). It is notable that when the
MHC region was removed from the pathway analysis,
the overall pattern of results remained (see Table S10).
To see whether the distinction between the concordant
and discordant subsets harbors potential implications
for drug targeting (for schizophrenia and/or cognitive
enhancement), we performed drug-based and drug family
competitive gene set analyses on our MAGMA results.
These analyses revealed that the class of drugs associated
with voltage-gated calcium channel genes was over-repre-
sented among in the results from the discordant subset
(Bonferroni-corrected p ¼ 0.02), as was Abacavir (nucleo-
side reverse transcriptase inhibitor; Bonferroni-corrected
p ¼ 0.00018). Although both of these sets showed similar
direction of effects with respect to the concordant subset,
no drug-related gene sets attained Bonferroni-corrected
significance in the results from the concordant subset
(Table S11).
S-Predixcan: Brain Tissue Expression Profiles and Gene-
Set Enrichment Analysis
Transcriptome-wide association analysis (TWAS) was car-
ried out via S-Predixcan to identify top expressed genes
within GTEXv746 and CommonMind Consortium54,56–58
brain tissue models (Figure 5 and Table S12). The top
brain-expressed genes unique to the discordant subsets
were CYP21A1P (MIM: 613815), CFB (MIM: 138470), and
C4A (MIM: 120810), along with 177 additional genes
that were significantly expressed in the discordant, but
not the concordant, subsets. On the other hand, ELOVL7
(MIM: 614451), NAGA (MIM: 609241), and 201 other
genes were uniquely associated with the concordant sub-
set. Significant genes identified by S-Predixcan were sub-
jected to GENE2FUNC hypergeometric gene-set analysis
(excluding MHC genes, which were over-represented due
to significant LD; see Material and Methods for more de-
tails). The goal of this analysis was to examine whether
the genes identified in the TWAS overlapped with those
found in known biological systems. As shown in Table 3,
the results of the TWAS consistently identified genes found
in cell adhesion and membrane protein gene sets for the
concordant subset. In contrast, synaptic (specifically den-
dritic) pathways, as well as chromosomal repair pathways,
were consistently identified by the TWAS during examina-
tion of the discordant subset.
Genetic Correlations
A series of psychiatric, personality, structural-brain-imag-
ing, metabolic, cardiovascular, and anthropometric traits
were selected for GNOVA modeling with the ASSET subset
results (see Figure 6 and Table S13); multiple testing was
adjusted on the basis of the false discovery rate (FDR).The
concordant subset demonstrated significant (FDR < .05)
Figure 4. Venn Diagram Comparing Significant ASSET Loci to
Significant Loci from Input GWASs
Education ¼ Okbay PMID 27225129; Cognition ¼ Lam PMID
29186694; Schizophrenia (Ripke) ¼ PGC Schizophrenia Working
Group PMID 25056061; ASSET ¼ results from ASSET meta-
analysis.
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genetic correlations, in the expected direction, with many
forms of psychopathology in addition to schizophrenia
(such forms included ADHD [MIM: 143465], bipolar disor-
der [MIM: 125480], and major depressive disorder [MDD,
MIM: 608516], as well as neuroticism and smoking). This
subset also demonstrated a significant (FDR < .05) positive
genetic correlation (i.e., better cognition/higher educa-
tion/lower risk for schizophrenia) with larger volumes of
several brain regions (including total intracranial volume)
as measured by structural MRI, as well as several measures
of infant size and adult height. Significant positive associ-
ations were also seen with the personality dimensions of
openness and conscientiousness, and (surprisingly) with
self-reported cancer; significant negative associations
were seen for total cholesterol and triglycerides, as well as
the presence of ulcerative colitis and inflammatory bowel
disease. Additionally, a negative genetic correlation was
observed for the concordant subset with BMI andmeasures
of cardiovascular disease (i.e., lower cognition/lower edu-
cation/greater risk for schizophrenia associated with
greater BMI and risk for cardiovascular disease).
The discordant subset was strongly associated with
schizophrenia and education, by definition, in a manner
demonstrating the paradoxical relationship (higher educa-
tion with greater risk for schizophrenia, Figure 6). (It is
important to note that the light blue bars and dark
blue bars in Figure 6 are essentially mirror images of each
other and are therefore providing somewhat redundant





End (bp) GWAS p Value Beta (b) SE Nearest Gene SNP Function
rs13010104 2 208331258 208369715 9.30 3 10-9 0.0148 0.0026 ENSG00000223725 ncRNA_intronic
rs207338 4 19053350 19070123 4.99 3 10-8 0.0108 0.0020 ENSG00000248238 intergenic
rs6844280 4 31371970 31387144 3.53 3 10-8 0.0113 0.0021 ENSG00000251434 intergenic
rs71615297 4 179013479 179210420 2.17 3 10-8 0.0115 0.0021 RNU1-45P intergenic
rs73260443 5 113404038 113464825 6.30 3 10-9 0.0147 0.0025 ENSG00000251628 intergenic
rs9372208 6 109507533 109648130 2.96 3 10-9 0.0120 0.0020 ENSG00000233908 intergenic
rs9371912 6 155907483 156009420 1.06 3 10-10 0.0168 0.0026 RNU7-152P intergenic
rs1870571 8 80129136 80296429 4.69 3 10-9 0.0124 0.0021 ENSG00000253659 intergenic
rs11786685 8 81220185 81316928 2.79 3 10-8 0.0116 0.0021 ENSG00000253237 intergenic
rs3890699 8 110164392 110344596 7.31 3 10-9 0.0122 0.0021 NUDCD1 intergenic
rs11166628 8 137022220 137091947 3.27 3 10-8 0.0113 0.0020 ENSG00000253248 ncRNA_intronic
rs10993909 9 136924744 136942560 3.13 3 10-8 0.0116 0.0021 BRD3 intronic
rs10994707 10 62919886 63096664 1.14 3 10-9 0.0202 0.0033 TMEM26 intergenic
rs72945305 11 81164016 81210528 3.34 3 10-8 0.0128 0.0023 ENSG00000254747 intergenic
rs556587 11 92317365 92554716 1.57 3 10-8 0.0163 0.0029 FAT3 intronic
rs75261250 11 124276497 124303201 2.16 3 10-8 0.0188 0.0034 OR8X1P intergenic
rs708212 12 31517960 31769501 7.79 3 10-9 0.0133 0.0023 DENND5B intronic
rs3741434 12 53605344 53605344 1.20 310-10 0.0191 0.0030 RARG UTR3
rs7321596 13 44390857 44514022 3.16 3 10-8 0.0109 0.0020 LACC1 intergenic
rs11617058 13 85176690 85305386 2.95 3 10-11 0.0183 0.0028 LINC00333 intergenic
rs67652508 14 55487496 55567991 2.88 3 10-8 0.0140 0.0025 MAPK1IP1L intergenic
rs11130 16 15687755 15837246 4.24 3 10-8 0.0110 0.0020 NDE1 UTR3
rs7214058 17 9968014 9995284 6.32 3 10-9 0.0118 0.0020 GAS7 intronic
rs28584904 17 68984046 69007006 2.36 3 10-8 0.0144 0.0026 ENSG00000271101 intergenic
rs56791590 18 26259012 26496051 7.59 3 10-9 0.0117 0.0020 ENSG00000265994 intergenic
rs12462428 19 16665215 16738369 2.20 3 10-8 0.0143 0.0026 ENSG00000141979:
MED26:CTC-429P9.4
intronic:intronic:intronic
rs5767976 22 48133458 48183889 8.14 3 10-10 0.0125 0.0020 RP11-191L9.4 ncRNA_intronic
rs68178377 22 50742346 50771464 4.28 3 10-8 0.0122 0.0022 DENND6B exonic
Abbreviations are as follows: Chr ¼ chromosome; SE ¼ standard error
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information; both sets of bars are included to indicate the
both sides of this dimension). Interestingly, a similar
pattern was observed for bipolar disorder (higher educa-
tion/greater risk for schizophrenia—greater risk for bipolar
disorder). Similar relationships were also observed, at a
nominally significant level, for autism spectrum disorder
and eating disorders (MIM: 606788), which were not asso-
ciated with the concordant subset, as well as for MDD. The
reverse relationship, however, was observed with ADHD
(i.e., higher education/greater risk for schizophrenia—
lower risk for ADHD). This pattern was also observed for
the smoking, BMI, and cardiovascular disease phenotypes.
A counter-intuitive pattern was observed for the relation-
ship between the discordant subset and neuroticism,
which was the opposite of that observed for MDD (despite
the fact that MDD and neuroticism are themselves highly
correlated).
Discussion
A consistent finding in recent schizophrenia, cognition,
and education GWASs has been the involvement of
both neurodevelopmental pathways and synaptic pro-
cesses;19,20,39,61,62,92 the present study aimed to at least
partially disentangle these mechanisms. In this study, we
leveraged the genetic pleiotropy underlying three partially
overlapping, complex phenotypes in order to identify ho-
mogeneous subsets of SNPs with distinct characteristics.
Specifically, we were able to parse a subset of SNPs with al-
leles that were associated in the expected fashion across
our three phenotypes of interest: lower cognitive ability,
lower educational attainment, and greater risk for schizo-
phrenia. These ‘‘concordant’’ SNPs were characterized by
their association with genes and pathways relevant to early
neurodevelopmental processes. By contrast, SNPs that
demonstrated a counterintuitive, discordant pattern of as-
sociation (higher educational attainment yet greater risk
for schizophrenia) were primarily associated with genes
and pathways involved in synaptic function of mature
neurons.
This distinction was robustly observed across several
methods of functional annotation. First, MAGMA compet-
itive gene-set analysis revealed a significant enrichment of
CHD8-related genes in the concordant subset (Table 2).
CHD8, encoding a chromatin remodeling protein, is a
gene that has been robustly associated with autism62–65
but that to date has only limited or anecdotal evidence
Table 2. MAGMA Significant Gene Sets for Concordant and Discordant SNP Subsets
Concordant
MAGMA Gene Sets NGENES p Pbon BETA BETA_STD SE
Cotney2015:hNSC_Chd8_prom* 8,186 4.05 3 10-9 7.11310-6 0.115 0.0571 0.0199
Cotney2015:hNSCþhumanþmouse_Chd8_prom 1,902 2.81 3 10-5 0.049458 0.123 0.0378 0.0304
Sugathan2014:Chd8_binding 5,314 1.69 3 10-5 0.029744 0.0874 0.04 0.0211
Discordant
Trapnell2012: constrained_genes_0_10* 1,705 3.41 3 10-7 0.0006 0.131 0.0383 0.0263
Lek2016: constrained_genes_pLI_90* 2,972 3.33 3 10-7 0.000585 0.104 0.0387 0.021
Darnell2011:fmrp_targets* 765 1.41 3 10-5 0.024693 0.162 0.0327 0.0387
ddg2p:dominant_mis_all_brain 137 4.42 3 10-6 0.007768 0.411 0.0357 0.0925
g2cdb:bayes_collins_mouse_psd_consensus* 918 8.89 3 10-6 0.015615 0.152 0.0333 0.0353
g2cdb:bayes_collins_mouse_psd_full* 1,442 1.26 3 10-6 0.002214 0.134 0.0363 0.0284
g2cdb:human_psd* 1,001 1.40 3 10-6 0.002461 0.159 0.0363 0.0339
g2cdb:human_psp* 1,039 2.04 3 10-6 0.003579 0.154 0.0358 0.0334
GOBP:membrane_depolarization 105 2.17 3 10-5 0.038129 0.439 0.0334 0.107
GOBP:synaptic_transmission 549 6.58 3 10-6 0.011554 0.205 0.0353 0.0471
GOMF:voltage-gated_cation_channel_activity* 144 6.43 3 10-7 0.00113 0.45 0.0401 0.093
Sanders2015:asd_fdr10* 64 4.67 3 10-6 0.008207 0.622 0.037 0.14
Sanders2015:asd_lof_genes* 559 3.52 3 10-6 0.006178 0.203 0.0352 0.0451
Abbreviations are as follows: NGENES ¼ number of genes in pathway; Pbon ¼ Bonferroni-corrected p value; BETA_STD ¼ standardized beta; GOBP ¼ gene
ontology biological process; GOMF ¼ gene ontology biological molecular function; Cotney ¼ PMID 25752243; hNSC ¼ human neural stem cells; prom ¼ pro-
motor; Sugathan ¼ PMID 25294932; Trapnell ¼ PMID 22383036; Lek ¼ PMID 27535533; Darnell ¼ PMID 21784246; ddg2p ¼ DECIPHER developmental dis-
order genotype-phenotype; dominant_mis_all_brain ¼ dominant mode of effect/loss-of-function missense/brain affected; g2cdb ¼ Genes2cognition database;
psd¼ post-synaptic density; psp¼ post-synaptic proteomes; Sanders¼ 26402605; asd_fdr_10¼ autism risk genes, FDR< 0.10; and asd_lof_genes¼ ASD loss-of-
function genes.
*Results remaining significant after removal of MHC region variants.
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for association to schizophrenia.66,67 Disruption of the ho-
mologous gene (Chd8) in animal models has demonstrated
that the resulting protein plays a key role in very early neu-
rodevelopmental processes, including neuronal prolifera-
tion and differentiation68,69 as well as cell adhesion and
axon guidance.70 On the other hand, MAGMA competi-
tive gene-set analysis revealed a significant enrichment of
discordant genes for functions including synaptic trans-
mission and postsynaptic density, as well as membrane de-
polarization and voltage-gated cation channel activity.
Although these processes have been commonly associated
with both schizophrenia33,35 and cognitive pheno-
types,20,21,24,71–74 our study is the first to demonstrate
that these synaptic mechanisms operate in a surprising
manner: the same synaptic functions that increase risk
for schizophrenia also serve to enhance educational
attainment.
The linkage of early neurodevelopmental processes to
SNPs associated with impaired cognition and increased
risk for schizophrenia is consistent with a large body of
literature demonstrating that cognitive deficits are often
observed early on in the lifespans of these individ-
uals.5,13,14,75At the same time, thediscordant variant subset
implicates more mature neuronal regulation, and synaptic
pruning mechanisms that are most prominent later in
childhood, adolescence, and into adulthood, ostensibly as
part of a neuroplasticity mechanism for makingmore ‘‘effi-
cient’’ connections within the brain.77 However, the dysre-
gulation of such mechanisms has been shown to be intri-
cately linked to schizophrenia psychopathology.78 It is
Figure 5. S-PrediXcan Transcriptome-
Wide Association Results
(A) Concordant and (B) discordant subsets.
important to note that these results
are obtained from separate GWASs of
two different phenotypes and do not
represent a subset of highly educated
individuals with schizophrenia.
Rather, it is plausible to posit an in-
verted U relationship such that effi-
cient synaptic pruning processes are
essential mechanisms underlying aca-
demic performance but might be car-
ried too far in disorders such as
schizophrenia.
Additionally, transcriptome-wide
analysis using S-Predixcan pointed to-
ward the same distinction between
concordant and discordant genes and
pathways. Two of the strongest genes
with differential expression in the
concordant subset were NAGA (an
enzyme cleaving specific moieties
from glycoconjugates) and NDUFAF2
(part of the mitochondrial complex
[MIM: 609653]); rare mutations in each of these genes are
associated with early and severe neurodevelopmental disor-
ders.79,80 TWAS of the discordant subset revealed synaptic
genes including C4A, which plays a key role in synaptic
pruning,78 as well as other genes essential to synapse struc-
ture and function; such genes include ARL3 (MIM:
604695), FXR1 (MIM: 600819), and CNNM2 (MIM:
607803). Moreover, pathway analysis of S-Predixcan results
(Table 3) demonstrated that the strongest gene set associ-
ated with the concordant subset was cell-to-cell adhe-
sion via plasma-membrane adhesion molecules (GO:
0098742); this gene set encompasses processes such as
those necessary for neural tube closure, cerebral cortex
migration, and neuronal-glial interactions. In contrast,
the discordant subset transcriptome was significantly en-
riched for genes located at dendrites, as well as for genes
associatedwithDNA repair. Recently, the role of DNA repair
in modulating neuronal activity-induced gene expression
has been shown to be crucial for synaptic plasticity and
related processes of learning and memory;81 impairments
in DNA repair have been linked to neurodegeneration82,83
ASSET also permitted the identification of SNPs for
cognition-related phenotypes. Lookups of the full
ASSET results revealed that 75% of the additional 110
loci, which were not identified in the input GWAS
studies,18,35,36 were in fact replicated in an MTAG study
examining intelligence20 and in more recent follow-up
GWASs20,33,34 that used larger samples and were better
powered for variant discovery. This result strongly supports
the validity of the ASSET methodology and demonstrates
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that the approach indeed improves power for cross-pheno-
type discovery of new loci, as previously discussed by the
developers of the method.32 Notably, several of our loci
were associated with eQTLs, suggesting new potential bio-
logical mechanisms for individual variation in cognitive
and psychiatric phenotypes. For example, one of the loci
strongly implicates variation in PLXNB2 (MIM: 604293),
a gene associated with GABA and glutamate synapses in
the hippocampus.84 Another locus shows strong eQTL
signal with NDE1 (MIM: 609449), a neurodevelopmental
gene at the 16p13.11 locus, where copy-number variants
have been associated with neurodevelopmental disor-
ders.85 Our work supports and extends a recent study by
Bansal and colleagues,30 whose paper is the only published
report (to our knowledge) that has deeply examined the
paradoxical relationship between educational attainment
and schizophrenia. Using a proxy-phenotype approach,
these investigators identified two loci, implicating the
FOXO6 (MIM: 611457) and SLITRK1 (MIM: 609678) genes,
with pleiotropic (i.e., ‘‘discordant’’) effects across the two
phenotypes. Using ASSET, we also uncovered those
genes among our 110 loci (one of which was also not iden-
tified in any of the updated single-phenotype GWAS, see
Table 1). Several other studies18,19,23,31 have employed
other statistical approaches to identify pleiotropy and/or
overlap across cognitive/educational and schizophrenia
GWAS and have uncovered a subset of the loci identified
by ASSET. By utilizing ASSET, we were able to systemati-
cally and powerfully identify concordant and discordant
pleiotropic loci across the genome and to then characterize
underlying biological mechanisms. Future studies could
also apply ASSET and related techniques to further under-
stand other reported polygenic overlaps such as that be-
tween schizophrenia and creativity86 or that between
cognitive ability and smoking status.26
In addition to functional characterization via pathway
analyses, we were able to characterize the concordant
and discordant SNP sets with respect to genetic overlap
with other relevant phenotypes. To our knowledge, this
is the first study to examine genetic correlations with
dimensional sub-sets rather than global correlations with
full GWASs. Although the concordant subset followed
the expected patterns of genetic correlation with several
forms of psychopathology, as well as brain and head size,
results for the discordant subset were somewhat surprising.
For example, we had anticipated that the discordant subset
Table 3. GENE2FUNC Pathway Analysis of GO Genesets with MHC Filtered




202 10 6.89 3 10-9 3.1 3 10-5
GO_bp GO_RESPONSE_TO_XENOBIOTIC_STIMULUS 105 7 6.22 3 10-8 2.8 3 10-4
GO_bp GO_HOMOPHILIC_CELL_ADHESION_VIA_PLASMA_MEMBRANE_
ADHESION_MOLECULES
151 8 7.74 3 10-8 3.4 3 10-4
GO_bp GO_CELL_CELL_ADHESION 604 14 4.46 3 10-7 2.0 3 10-3
GO_mf GO_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_QUINONE_
OR_SIMILAR_COMPOUND_AS_ACCEPTOR
52 4 6.39 3 10-6 5.8 3 10-3
GO_cc GO_MEMBRANE_MICRODOMAIN 286 8 1.53 3 10-5 8.9 3 10-3
GO_cc GO_MEMBRANE_PROTEIN_COMPLEX 1018 16 1.58 3 10-5 9.2 3 10-3
GO_bp GO_PURINE_RIBONUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS 20 3 2.77 3 10-6 1.2 3 10-2
GO_cc GO_MITOCHONDRION 1633 21 2.47 3 10-5 1.4 3 10-2
GO_bp GO_BIOLOGICAL_ADHESION 1027 17 4.56 3 10-6 2.0 3 10-2
GO_bp GO_MACROMOLECULAR_COMPLEX_ASSEMBLY 1388 20 6.87 3 10-6 3.0 3 10-2
GO_bp GO_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_I_
BIOGENESIS
56 4 9.25 3 10-6 4.1 3 10-2
Discordant
GO_cc GO_DENDRITIC_SHAFT 37 3 1.28 3 10-5 7.4 3 10-3
GO_bp GO_DOUBLE_STRAND_BREAK_REPAIR 165 6 3.89 3 10-6 1.7 3 10-2
GO_cc GO_NUCLEAR_CHROMOSOME 522 9 3.84 3 10-5 2.2 3 10-2
GO_mf GO_PROTEIN_DOMAIN_SPECIFIC_BINDING 620 10 3.14 3 10-5 2.8 3 10-2
GO_bp GO_NON_RECOMBINATIONAL_REPAIR 70 4 7.97 3 10-6 3.5 3 10-2
GO_cc GO_DENDRITE 451 8 6.94 3 10-5 4.0 3 10-2
Note: N_gene ¼ Genes identified in pathway; N_overlap ¼ input genes overlapping with pathway; Pbon ¼ Bonferoni-adjusted p value
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might be significantly related to personality as a non-
cognitive trait that could promote greater educational
attainment. However, correlations with conscientiousness,
openness, and neuroticism were stronger for the concor-
dant than for the discordant subset.
On the other hand, significant correlations for the
discordant subset were observed with risk for autism,
which has previously been shown to demonstrate a
counter-intuitive positive genetic correlation with cogni-
tion.87 Given that variants within the discordant subset
tend to index regulation of synaptic function and pruning
processes, our results suggest that these mechanisms
should be investigated with respect to their impact on
autism, eating disorders, and bipolar disorder. Moreover,
it is noteworthy that autism, despite being a neurode-
velopmental disorder, did not demonstrate a significant ge-
Figure 6. Genetic Correlations for
Concordant and Discordant Subsets with
Other Relevant Phenotypes
Genetic correlation analysis was carried
out with GNOVA. Error bars represent
standard errors. Summary statistics of
selected phenotypes were downloaded
from the LD Hub and Psychiatric Geno-
mics Consortium websites. See Web Re-
sources for further detail.
netic correlation with the concordant
subset, indicating that it does not
share the specific neurodevelopmen-
tal pathways implicated in the com-
mon variant genetic overlap between
schizophrenia risk and impaired
cognition. It is also intriguing that bi-
polar disorder demonstrated a very
similar pattern of GNOVA results to
schizophrenia, despite prior reports
that bipolar disorder is not signifi-
cantly correlated at the genetic level
with general cognitive ability.87,88
Thus, our approach was able to
refine components of neurodevelop-
ment and synaptic function that
are shared across cognitive pheno-
types, schizophrenia, and bipolar dis-
order. Further research is needed to
identify components of cognition
that differentiate schizophrenia and
bipolar disorder.
One limitation of this study is that
only common SNPs (MAF > 0.01)
were examined. The genetic architec-
ture of cognitive ability and educa-
tional attainment is composed of
causal variants in LD with common
SNPs (cognitive ability h2 ¼ 22.7%,
education h2 ¼ 15.6%) as well as
with causal variants in LD with rare and less-common
SNPs (cognitive ability h2 ¼ 31.3%, education h2 ¼
28.1%); rarer variants make greater contributions to cogni-
tive differences than more common variants do.89 Rare
variants are also known to explain some of the differences
in schizophrenia prevalence.50 However, GNOVA, used in
the identification of genetic correlations across data-inde-
pendent datasets using summary GWAS data, can only
capture the contributions made by common genetic ef-
fects. Future work aiming to investigate the concordant
and discordant effect of rare variants across cognitive abil-
ity, schizophrenia, and education is needed.90 Addition-
ally, the input GWASs for ASSET were of somewhat
different sample sizes and power, and the cognitive
GWAS demonstrated smaller mean effect sizes than those
for schizophrenia and educational attainment; the effects
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of such differences on ASSET results are not fully under-
stood, although ASSET has been benchmarked as the best
available approach to handling non-uniform distribution
of effect sizes.39
Now that the utility and validity of the ASSET approach
has been demonstrated, future studies are planned that
can further exploit this method using larger, and more
varied, input GWASs. Recent studies have demonstrated
that genetic correlations exist across seemingly disparate
brain-related phenotypes.91 However, such genetic corre-
lations only describe the average genetic effect between
pairs of traits. As such, they are not informative as to
which variants are associated across traits, nor if a minor-
ity of these variants have effects across traits that are the
opposite of what would be expected on the basis of the
direction of the genetic correlation. The application of
the ASSET approach to these datasets would help re-
searchers to move beyond the analysis of shared genetic
variance and begin to identify shared genetic variants
that, as shown in the current study, might be composed
of variants with different combinations of protective
and deleterious effects. Future studies, employing addi-
tional statistical techniques and incorporating rare vari-
ants and novel annotation resources, are needed to
further decompose the early neurodevelopmental and
adult synaptic pathways highlighted in the present
report.
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